Back

Analysis of recurrent research pathways for assessing and improving effectiveness in life sciences laboratories

Balas, E. A.; Patel, C.; Ewing, B.; Patel, N.; McCoy, T. C.; Wise, S.; Abdelgawad, Y. H.

2023-01-10 health systems and quality improvement
10.1101/2023.01.09.23284360 medRxiv
Show abstract

BackgroundLife sciences research often turns out to be ineffective. Our aim was to develop a method for mapping repetitive research processes, detecting practice variations, and exploring inefficiencies. MethodsThree samples of R&I projects were used: companion diagnostics of cancer treatments, identification of COVID-19 variants, and COVID-19 vaccine development. Major steps involved: defined starting points, desired end points; measurement of transition times and success rates; exploration of variations, and recommendations for improved efficiency. ResultsOver 50% of CDX developments failed to reach market simultaneously with new drugs. There were significant variations among phases of co-development (Bartlett test P<0.001). Length of time in vaccine development also shows variations (P<0.0001). Similarly, subject participation indicates unexplained variations in trials (Phase I: 489.7 ({+/-}461.8); Phase II: 857.3 ({+/-}450.1); Phase III: 35402 ({+/-}18079). ConclusionAnalysis of repetitive research processes can highlight inefficiencies and show ways to improve quality and productivity in life sciences.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.